DECIBEL THERAPEUTICS INC (DBTX)
US24343R1068 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -63.39M | -63.01M | -51.82M | -39.34M | -42.67M | |||
| Depreciation Amortization | 1.40M | 1.46M | 1.41M | 1.64M | 1.77M | |||
| Change In Working Capital | 8.40M | -618.00K | 3.49M | 2.25M | -8.69M | |||
| Interest Paid | N/A | 14.00K | 34.00K | 20.00K | N/A | |||
| Taxes Paid | N/A | N/A | 0.00 | 10.00K | 10.00K | |||
| Other non cash items | 4.79M | 5.26M | 3.77M | 2.78M | 180.00K | |||
| OPERATING CASH FLOW | -48.81M | -56.90M | -43.15M | -32.66M | -49.41M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -496.00K | -463.00K | -745.00K | -270.00K | -720.00K | |||
| Other Investing Activity | 32.23M | 55.56M | -100.25M | -12.74M | 58.05M | |||
| INVESTING CASH FLOW | 31.74M | 55.10M | -101.00M | -13.01M | 57.34M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -136.00K | -213.00K | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 430.00K | 0.00 | 152.70M | 54.43M | -10.00K | |||
| Other Financing Activity | N/A | N/A | -193.00K | 420.00K | N/A | |||
| FINANCING CASH FLOW | 294.00K | -213.00K | 152.51M | 54.85M | -10.00K | |||
| CHANGE IN CASH | -16.77M | -2.01M | 8.36M | 9.18M | 7.92M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -48.81M | -56.90M | -43.15M | -32.66M | -49.41M | |||
| Capital Expenditure | -496.00K | -463.00K | -745.00K | -270.00K | -720.00K | |||
| FREE CASH FLOW | -49.30M | -57.36M | -43.89M | -32.93M | -50.13M | |||
All data in USD